Answer
Women of childbearing potential should use effective contraception throughout brolucizumab treatment and for at least one month after the last dose when stopping treatment.
Sources for this answer
- Beovu 120 mg/ml solution for injection in pre filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked